Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:FLDM

Fluidigm (FLDM) Stock Price, News & Analysis

Fluidigm logo

About Fluidigm Stock (NASDAQ:FLDM)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
$3.27
$3.99
52-Week Range
N/A
Volume
60,126 shs
Average Volume
968,838 shs
Market Capitalization
$283.76 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive FLDM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Fluidigm and its competitors with MarketBeat's FREE daily newsletter.

FLDM Stock News Headlines

The MAGA 7 Stocks: Huge Upside in 2025
The Trump economy is back in full force, and it’s creating huge opportunities for investors. With Trump pushing for lower taxes, fewer regulations, tariffs on foreign competitors, and domestic manufacturing dominance, some stocks are set to skyrocket in value—while others will be left behind. That’s why we put together this free report revealing the 7 MAGA stocks poised to thrive in 2025.
Here's what Wall Street expects from Fluidigm's earnings
T2 Biosystms Inc (TTOO)
Standard BioTools (NASDAQ: FLDM)
See More Headlines

FLDM Stock Analysis - Frequently Asked Questions

Fluidigm Co. (NASDAQ:FLDM) announced its quarterly earnings results on Sunday, November, 7th. The medical research company reported ($0.18) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.22) by $0.04. The medical research company earned $28.50 million during the quarter. Fluidigm had a negative trailing twelve-month return on equity of 40.15% and a negative net margin of 45.36%.

Based on aggregate information from My MarketBeat watchlists, some other companies that Fluidigm investors own include Himax Technologies (HIMX), OPKO Health (OPK), Sorrento Therapeutics (SRNE), Moderna (MRNA), Pfizer (PFE), Accelerate Diagnostics (AXDX) and Meta Platforms (META).

Company Calendar

Last Earnings
11/07/2021
Today
7/13/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Analytical Instruments
Sub-Industry
Life Sciences Tools & Services
Current Symbol
NASDAQ:FLDM
CIK
1162194
Employees
615
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($0.78)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$59.24 million
Net Margins
-45.36%
Pretax Margin
-48.75%
Return on Equity
-40.15%
Return on Assets
-14.86%

Debt

Debt-to-Equity Ratio
0.68
Current Ratio
1.45
Quick Ratio
1.03

Sales & Book Value

Annual Sales
$130.58 million
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$1.24 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
76,486,000
Free Float
74,268,000
Market Cap
$283.76 million
Optionable
Optionable
Beta
1.14

Social Links

2025 Gold Forecast: A Perfect Storm for Demand Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

This page (NASDAQ:FLDM) was last updated on 7/13/2025 by MarketBeat.com Staff
From Our Partners